# Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

> **NCT05572983** · PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 47 (estimated)

## Conditions studied

- Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

## Interventions

- **DRUG:** Chidamide combined with CHOP
- **DRUG:** Chidamide

## Key facts

- **NCT ID:** NCT05572983
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05572983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05572983, "Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05572983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*